Free Trial
Looking for inspirations for innovation challenges? Try Patsnap Eureka!

Top 5 Key Players companies in Ophthalmology
by Most News Heat in the China in 2018

The Ophthalmology top 5 is Discovery PatSnap’ annual ranking of the top 5 Most News Heat Ophthalmology Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

2020

2019

2018

Region:

Global

China

Japan

Switzerland

United States

United Kingdom

Denmark

Germany

France

Italy

Canada

Ranking:

Most Market Reports

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
Tiandi Science & Technology Co., Ltd.
Beijing Shi, China
Coal,Oil well,Manufacturing engineering,
...[+2]
news: 3
2
Global PMX Co., Ltd.
Taiwan Province, China
Semiconductor,Electronics,Computer hardware,
...[+2]
news: 3
3
Edmond De Rothschild Investment Partners (Shanghai) Ltd.
Shanghai Shi, China
Alternative investment,Asset management,Gene delivery,
...[+2]
news: 3
4
Fosun International Ltd.
Shanghai Shi, China
Angel investor,Secondary market,Medical tourism,
...[+2]
news: 2
5
SINOPEC Engineering (Group) Co., Ltd.
Beijing Shi, China
Construction engineering,Chemical engineering,Oil well,
...[+2]
news: 2

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Nov 21 2024
For better visiting experience, please use PC device.X